SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-209864
Filing Date
2021-07-07
Accepted
2021-07-07 16:01:34
Documents
12
Period of Report
2021-07-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d184046d8k.htm   iXBRL 8-K 22894
  Complete submission text file 0001193125-21-209864.txt   141397

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nvta-20210705.xsd EX-101.SCH 2915
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvta-20210705_lab.xml EX-101.LAB 17373
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvta-20210705_pre.xml EX-101.PRE 10968
5 EXTRACTED XBRL INSTANCE DOCUMENT d184046d8k_htm.xml XML 3273
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 211077436
SIC: 8071 Services-Medical Laboratories